dr. pal on developments in frontline treatments for patients with mrcc
Published 5 years ago • 104 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
0:19
copy of dr. pal on developments in frontline treatments for patients with mrcc
-
0:51
dr. pal on the frontline approval of nivolumab and ipilimumab in mrcc
-
1:01
dr. pal on sequencing challenges for the treatment of patients with rcc
-
0:48
dr. pal on preoperative immunotherapy in patients with rcc
-
13:24
special series on rcc: beyond first-line treatment strategies for mrcc with dr. mari and dr. cicc...
-
10:14
supporting dignity and quality of life through illness | dr caryn khoo (palliative care consultant)
-
56:59
renal cell carcinoma
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
0:50
dr. pal on the benefit of tivozanib in later-line settings for refractory rcc
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
1:01
dr. ho on frontline treatment regimens in mrcc
-
0:41
dr. pal on molecular signatures in renal cell carcinoma
-
1:06
dr. pal on crispr-based technology in rcc
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
0:29
copy of dr. pal on the clinical utility of pd-l1 in mrcc
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
-
1:41
dr. choueiri on next steps for treatment in rcc
-
1:03
dr. pal on the sequencing of immunotherapy for urothelial carcinoma
-
1:41
dr gong on the frontline use of parp inhibitors in mcrpc
-
7:15
introduction: multidisciplinary frontline treatment of metastatic renal cell carcinoma
-
0:43
dr. pal on sequencing nivolumab in rcc
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer